Darren Mansfield
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Darren Mansfield has a total of 194 co-authors. Here are the top co-authors by number of shared publications:
- Garun S. Hamilton
Monash Lung, Sleep, Allergy & Immunology Monash Health Melbourne Victoria Australia
5 shared publications - Bradley A. Edwards
School of Psychological Sciences, Monash University, Melbourne, Australia
4 shared publications - Shane Anthony Landry
Department of Physiology, Biomedical Discovery Institute, Monash University, Melbourne, VIC, Australia; School of Psychological Sciences, Monash University, Melbourne, VIC, Australia
4 shared publications - Shantha Mw Rajaratnam
Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States
4 shared publications Nur K. Abdul Jafar
Monash Centre for Health Research and Implementation Clayton Victoria Australia
3 shared publications- Simon A. Joosten
Monash Lung and Sleep, Monash Medical Centre, Clayton, VIC, Australia
3 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in ATS Scholar
Flexible Nasolaryngoscopy for Pulmonologists: Narrative Review
Background: Flexible nasolaryngoscopy (FNL) enables dynamic visualization of the upper and ‘middle’ airways. Traditionally performed by otolaryngologists, FNL is of increasing relevance to pulmonology. Integrating FNL into everyday pulmonology practice could provide critical, management-altering data, facilitate timely diagnosis and optimized management of complex clinical presentations. Objective: To delineate the role, indications, and training needs for FNL in adult pulmonology, and to summarize existing models of competency development relevant to pulmonologists. Methods: A narrative review was performed using MEDLINE from database inception to November 2025. Sources included specialty guidelines, educational reports, and competency frameworks, with the aim of synthesizing evidence for pulmonology-focused training integration. Results: Several indications for FNL are relevant to pulmonologists in day-to-day practice including breathlessness, chronic cough, and hemoptysis. FNL enables point-of-care evaluation of upper/middle airway pathologies. Existing competency frameworks focus on simulation, structured supervision, and workplace-based assessments rather than procedural volume. Comparable principles can inform a pulmonology-led FNL curriculum using established bronchoscopy training infrastructure. Potential gaps include simulation access, credentialing structures, and validated performance metrics. Conclusion: FNL represents a natural extension of pulmonology, enabling diagnostic precision, integrated airway care, and holistic, patient-centered holistic management. Development of structured, competency-based, multidisciplinary training and assessment pathways for FNL is essential to ensure safe, standardized practice in pulmonology.
- 10 November 2026
- Published by Oxford University Press (OUP) in ATS Scholar
Open AccessFlexible Nasolaryngoscopy for Pulmonologists: Narrative Review
Background: Flexible nasolaryngoscopy (FNL) enables dynamic visualization of the upper and ‘middle’ airways. Traditionally performed by otolaryngologists, FNL is of increasing relevance to pulmonology. Integrating FNL into everyday pulmonology practice could provide critical, management-altering data, facilitate timely diagnosis and optimized management of complex clinical presentations. Objective: To delineate the role, indications, and training needs for FNL in adult pulmonology, and to summarize existing models of competency development relevant to pulmonologists. Methods: A narrative review was performed using MEDLINE from database inception to November 2025. Sources included specialty guidelines, educational reports, and competency frameworks, with the aim of synthesizing evidence for pulmonology-focused training integration. Results: Several indications for FNL are relevant to pulmonologists in day-to-day practice including breathlessness, chronic cough, and hemoptysis. FNL enables point-of-care evaluation of upper/middle airway pathologies. Existing competency frameworks focus on simulation, structured supervision, and workplace-based assessments rather than procedural volume. Comparable principles can inform a pulmonology-led FNL curriculum using established bronchoscopy training infrastructure. Potential gaps include simulation access, credentialing structures, and validated performance metrics. Conclusion: FNL represents a natural extension of pulmonology, enabling diagnostic precision, integrated airway care, and holistic, patient-centered holistic management. Development of structured, competency-based, multidisciplinary training and assessment pathways for FNL is essential to ensure safe, standardized practice in pulmonology.
- 31 October 2026
- Published by Wiley in Internal Medicine Journal
Clinical utility of bronchoalveolar lavage in immunocompromised patients with pulmonary infiltrates: impact on diagnostic yield and management
Background: Pulmonary infiltrates in immunocompromised patients are associated with high morbidity and mortality, and accurate diagnosis is often challenging due to overlapping infectious and non‐infectious aetiologies. Flexible bronchoscopy with bronchoalveolar lavage (BAL) is widely used, but its contemporary real‐world clinical utility across heterogeneous immunocompromised populations remains uncertain. Aims: To retrospectively evaluate the clinical utility of inpatient flexible bronchoscopy with BAL in immunocompromised adults presenting with new pulmonary infiltrates at a tertiary referral centre. Methods: Retrospective cohort study conducted at a Victorian tertiary centre including immunocompromised adults who underwent inpatient flexible bronchoscopy for new CT‐confirmed pulmonary infiltrates between January 2022 and December 2024. The primary outcomes were diagnostic yield and the proportion of procedures resulting in a change in clinical management. Results: Sixty‐two patients were included (mean age 60.3 ± 16.9 years; 38.7% female). Patients with underlying haematological malignancy accounted for 59.7% of cases, and 83.9% were receiving empiric antibiotic therapy prior to bronchoscopy. Overall diagnostic yield was 43.5% (27/62). Bronchoscopy resulted in a change in clinical management in 64.5% of cases (40/62), most commonly initiation of targeted antimicrobial therapy (47.5%). The median interval from imaging to bronchoscopy was 4.5 days. Procedural complications were uncommon and limited (4.8%). Patients with haematological malignancy had higher odds of fungal infection (OR 6.81, 95% CI 1.33–68.54; P = 0.009) and mortality at 12 months (51.4% vs 20.0%; OR 4.22, CI 1.17–17.16, P = 0.017) compared to non‐haematological causes of immunocompromise. Conclusion: In immunocompromised inpatients with pulmonary infiltrates, bronchoscopy with BAL was associated with frequent changes in clinical management and a low rate of procedure‐related complications. These observational findings support its use in appropriately selected patients, while prospective studies are needed to determine its effect on patient‐centred outcomes.
- 31 October 2026
- Published by Wiley in Internal Medicine Journal
Clinical utility of bronchoalveolar lavage in immunocompromised patients with pulmonary infiltrates: impact on diagnostic yield and management
Background: Pulmonary infiltrates in immunocompromised patients are associated with high morbidity and mortality, and accurate diagnosis is often challenging due to overlapping infectious and non‐infectious aetiologies. Flexible bronchoscopy with bronchoalveolar lavage (BAL) is widely used, but its contemporary real‐world clinical utility across heterogeneous immunocompromised populations remains uncertain. Aims: To retrospectively evaluate the clinical utility of inpatient flexible bronchoscopy with BAL in immunocompromised adults presenting with new pulmonary infiltrates at a tertiary referral centre. Methods: Retrospective cohort study conducted at a Victorian tertiary centre including immunocompromised adults who underwent inpatient flexible bronchoscopy for new CT‐confirmed pulmonary infiltrates between January 2022 and December 2024. The primary outcomes were diagnostic yield and the proportion of procedures resulting in a change in clinical management. Results: Sixty‐two patients were included (mean age 60.3 ± 16.9 years; 38.7% female). Patients with underlying haematological malignancy accounted for 59.7% of cases, and 83.9% were receiving empiric antibiotic therapy prior to bronchoscopy. Overall diagnostic yield was 43.5% (27/62). Bronchoscopy resulted in a change in clinical management in 64.5% of cases (40/62), most commonly initiation of targeted antimicrobial therapy (47.5%). The median interval from imaging to bronchoscopy was 4.5 days. Procedural complications were uncommon and limited (4.8%). Patients with haematological malignancy had higher odds of fungal infection (OR 6.81, 95% CI 1.33–68.54; P = 0.009) and mortality at 12 months (51.4% vs 20.0%; OR 4.22, CI 1.17–17.16, P = 0.017) compared to non‐haematological causes of immunocompromise. Conclusion: In immunocompromised inpatients with pulmonary infiltrates, bronchoscopy with BAL was associated with frequent changes in clinical management and a low rate of procedure‐related complications. These observational findings support its use in appropriately selected patients, while prospective studies are needed to determine its effect on patient‐centred outcomes.
- 25 February 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (8) , e2006-e2017
Childhood sleep behaviors and polycystic ovary syndrome risk in adolescence: the Raine study cohort longitudinal study
Background: Sleep disturbances are common in women with polycystic ovary syndrome (PCOS), but no prospective studies have explored whether childhood–adolescence sleep disturbances are associated with later PCOS risk. Understanding behavioral markers may support early identification and intervention. Objective: To examine whether poor sleep behaviors from childhood to adolescence are prospectively associated with a diagnosis of PCOS at age 14 years. Materials and methods: Sleep behavior data (Child Behavior Checklist) from a longitudinal study of 226 female participants of the Raine Study cohort (37 with PCOS), assessed at ages 5, -8, -10, and -14 years, with PCOS diagnosis at age 14 years were analyzed. PCOS diagnosis was based on both hyperandrogenism and ovulatory dysfunction according to the 2023 PCOS Guideline adolescent diagnostic criteria. Generalized estimating equations examined longitudinal sleep behavior differences by PCOS status at age 14; logistic regression explored specific sleep behavior associations with PCOS risk at age 14. Results: After adjustment for covariates, results showed higher sleep behavior problem scores from childhood to adolescence, with differences becoming more pronounced over time among girls with PCOS at age 14 (adjusted mean difference = 0.49; 95% CI = 0.10-0.87; P = .013). Analysis of individual items showed significant associations between PCOS at age 14 and “trouble sleeping” at age 10 (odds ratio [OR] = 2.95; 95% CI = 1.30-6.69) and “sleeping less than most kids” at age 10 (OR = 2.48; 95% CI = 1.18-5.22). Conclusion: Sleep difficulties may serve as early, modifiable behavioral markers of PCOS risk. Poor sleep may worsen hormonal and metabolic dysfunction, promoting insulin resistance, obesity, and sleep disturbances.
- 25 February 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (8) , e2006-e2017
Childhood sleep behaviors and polycystic ovary syndrome risk in adolescence: the Raine study cohort longitudinal study
Background: Sleep disturbances are common in women with polycystic ovary syndrome (PCOS), but no prospective studies have explored whether childhood–adolescence sleep disturbances are associated with later PCOS risk. Understanding behavioral markers may support early identification and intervention. Objective: To examine whether poor sleep behaviors from childhood to adolescence are prospectively associated with a diagnosis of PCOS at age 14 years. Materials and methods: Sleep behavior data (Child Behavior Checklist) from a longitudinal study of 226 female participants of the Raine Study cohort (37 with PCOS), assessed at ages 5, -8, -10, and -14 years, with PCOS diagnosis at age 14 years were analyzed. PCOS diagnosis was based on both hyperandrogenism and ovulatory dysfunction according to the 2023 PCOS Guideline adolescent diagnostic criteria. Generalized estimating equations examined longitudinal sleep behavior differences by PCOS status at age 14; logistic regression explored specific sleep behavior associations with PCOS risk at age 14. Results: After adjustment for covariates, results showed higher sleep behavior problem scores from childhood to adolescence, with differences becoming more pronounced over time among girls with PCOS at age 14 (adjusted mean difference = 0.49; 95% CI = 0.10-0.87; P = .013). Analysis of individual items showed significant associations between PCOS at age 14 and “trouble sleeping” at age 10 (odds ratio [OR] = 2.95; 95% CI = 1.30-6.69) and “sleeping less than most kids” at age 10 (OR = 2.48; 95% CI = 1.18-5.22). Conclusion: Sleep difficulties may serve as early, modifiable behavioral markers of PCOS risk. Poor sleep may worsen hormonal and metabolic dysfunction, promoting insulin resistance, obesity, and sleep disturbances.
- 14 May 2025
- Published by Wiley in Respirology
- Vol. 30 (7) , 555-557
Obstructive Sleep Apnoea Screening and Diagnosis Across Adult Populations: Are We Ready?
- 14 May 2025
- Published by Wiley in Respirology
- Vol. 30 (7) , 555-557
Obstructive Sleep Apnoea Screening and Diagnosis Across Adult Populations: Are We Ready?
- Open Access
- 4 April 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1532519
Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Background: Polycystic ovary syndrome (PCOS) has been associated with a high prevalence of obstructive sleep apnea syndrome (OSAS). However, the impact of OSAS on the PCOS symptom profile remains unclear. This systematic review and meta-analysis, which informed the 2023 International Evidence-based PCOS Guideline, aims to assess the prevalence and related symptoms of OSAS among females with and without PCOS.Methods: A systematic search using databases (MEDLINE, Embase, EBM Reviews, PsycInfo and CINAHL) was performed until 16th May 2024. Random-effects restricted maximum likelihood meta-analyses compared OSAS and related symptoms between PCOS and non-PCOS groups. OSAS outcomes were categorized as apnea-hypopnea index (AHI)≥5 only, AHI≥5 with symptoms, AHI≥10 with symptoms and composite OSA (i.e., all AHI cut-offs with and/or without symptoms). Subgroup analyses by body mass index (BMI), age, PCOS diagnostic criteria and ethnicity were performed. Risk of bias and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework were conducted.Results: From 4438 records, 3205 titles/abstracts were screened and 40 were eligible for full-text screening. Eight cross-sectional studies met inclusion criteria and meta-analysis. The pooled prevalence of OSA was 37.0% in PCOS (29.0% adolescents; 40.0% adults) and 6.0% in non-PCOS. Compared with non-PCOS, those with PCOS showed higher risk for composite OSA (odds ratio (OR): 9.52; 95% CI: 3.90 to 23.26; I2 = 54.5%; 8 studies, n=942; PP ≤ 0.0023). Subgroup results showed significantly higher risk of OSAS overall in overweight/obesity, adults and white ethnicity compared with normal weight, adolescent and Asian subgroups, respectively (all P<0.001), but independent of PCOS diagnostic criteria.Conclusion: The prevalence of OSA was higher in PCOS compared with non-PCOS groups, with the risk of OSAS increasing with worse symptom severity. Adults and those of higher BMI and of white ethnicity were at increased risk of OSAS. Hence, identifying and treating OSAS symptoms in PCOS may be beneficial, but further validation of findings is warranted.
- 4 April 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1532519
Open AccessObstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
Background: Polycystic ovary syndrome (PCOS) has been associated with a high prevalence of obstructive sleep apnea syndrome (OSAS). However, the impact of OSAS on the PCOS symptom profile remains unclear. This systematic review and meta-analysis, which informed the 2023 International Evidence-based PCOS Guideline, aims to assess the prevalence and related symptoms of OSAS among females with and without PCOS.Methods: A systematic search using databases (MEDLINE, Embase, EBM Reviews, PsycInfo and CINAHL) was performed until 16th May 2024. Random-effects restricted maximum likelihood meta-analyses compared OSAS and related symptoms between PCOS and non-PCOS groups. OSAS outcomes were categorized as apnea-hypopnea index (AHI)≥5 only, AHI≥5 with symptoms, AHI≥10 with symptoms and composite OSA (i.e., all AHI cut-offs with and/or without symptoms). Subgroup analyses by body mass index (BMI), age, PCOS diagnostic criteria and ethnicity were performed. Risk of bias and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework were conducted.Results: From 4438 records, 3205 titles/abstracts were screened and 40 were eligible for full-text screening. Eight cross-sectional studies met inclusion criteria and meta-analysis. The pooled prevalence of OSA was 37.0% in PCOS (29.0% adolescents; 40.0% adults) and 6.0% in non-PCOS. Compared with non-PCOS, those with PCOS showed higher risk for composite OSA (odds ratio (OR): 9.52; 95% CI: 3.90 to 23.26; I2 = 54.5%; 8 studies, n=942; PP ≤ 0.0023). Subgroup results showed significantly higher risk of OSAS overall in overweight/obesity, adults and white ethnicity compared with normal weight, adolescent and Asian subgroups, respectively (all P<0.001), but independent of PCOS diagnostic criteria.Conclusion: The prevalence of OSA was higher in PCOS compared with non-PCOS groups, with the risk of OSAS increasing with worse symptom severity. Adults and those of higher BMI and of white ethnicity were at increased risk of OSAS. Hence, identifying and treating OSAS symptoms in PCOS may be beneficial, but further validation of findings is warranted.
- Open Access
- 20 August 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (4) , 129-130
Letter to the Editor: Mineralocorticoid receptor antagonists in adults with resistant hypertension and obstructive sleep apnoea
Small studies of mineralocorticoid receptor antagonists have demonstrated significant effects on blood pressure and sleep apnoea symptoms in people with OSA associated with resistant hypertension.
- 20 August 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (4) , 129-130
Open AccessLetter to the Editor: Mineralocorticoid receptor antagonists in adults with resistant hypertension and obstructive sleep apnoea
Small studies of mineralocorticoid receptor antagonists have demonstrated significant effects on blood pressure and sleep apnoea symptoms in people with OSA associated with resistant hypertension.
- Open Access
- 23 April 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (2) , 52-56
Diagnosis and management of obstructive sleep apnoea in adults
Diagnosis and management of obstructive sleep apnoea is important. Untreated sleep apnoea results in non-restorative sleep and daytime sleepiness, and may lead to adverse long-term cardiovascular and neurocognitive outcomes.
- 23 April 2024
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 47 (2) , 52-56
Open AccessDiagnosis and management of obstructive sleep apnoea in adults
Diagnosis and management of obstructive sleep apnoea is important. Untreated sleep apnoea results in non-restorative sleep and daytime sleepiness, and may lead to adverse long-term cardiovascular and neurocognitive outcomes.
- Open Access
- 1 October 2023
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 4 (Supplement) , A54
P051 Associations between Chronotype and Symptoms of Depression in Patients attending an Outpatient Sleep Clinic
Chronotype (or morningness-eveningness), individuals’ time-of-the-day preference for activity, has been associated with depressive symptoms. This cross-sectional study examined the association between chronotype and symptoms of depression in outpatients attending a sleep disorders clinic. The sample included individuals attending an outpatient sleep disorders clinic and provided opt-out consent for their data to be used for research purposes. Individuals included in the analyses provided demographic data, their typical weekly total sleep time (TST), and complete responses prior to treatment on the reduced Morningness-Eveningness Questionnaire (rMEQ; for chronotype), and the PROMIS depression scale. A total of 1641 (44.5% female, Mage = 45.20 years, SDage = 16.06 years) participants were included. On average, the sample scored intermediate chronotype (M = 14.73, SD = 4.35) and higher depressive symptom scores that were half a standard deviation higher compared to community norms (M = 55.80, SD = 10.01). Multiple linear regression controlling for age, sex, and TST showed that greater eveningness preferences predicted higher symptoms of depression, p<0.01, explaining 2.76% additional variance in depression scores above that of the covariates. Overall, sleep clinic outpatients had an intermediate chronotype and above average depressive symptoms. The findings are consistent with existing literature in other populations indicating that eveningness may be a risk factor for greater symptoms of depression. Future studies need to explore whether interventions to alter chronotype may benefit symptoms of depression in individuals with sleep complaints.
- 1 October 2023
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 4 (Supplement) , A54
Open AccessP051 Associations between Chronotype and Symptoms of Depression in Patients attending an Outpatient Sleep Clinic
Chronotype (or morningness-eveningness), individuals’ time-of-the-day preference for activity, has been associated with depressive symptoms. This cross-sectional study examined the association between chronotype and symptoms of depression in outpatients attending a sleep disorders clinic. The sample included individuals attending an outpatient sleep disorders clinic and provided opt-out consent for their data to be used for research purposes. Individuals included in the analyses provided demographic data, their typical weekly total sleep time (TST), and complete responses prior to treatment on the reduced Morningness-Eveningness Questionnaire (rMEQ; for chronotype), and the PROMIS depression scale. A total of 1641 (44.5% female, Mage = 45.20 years, SDage = 16.06 years) participants were included. On average, the sample scored intermediate chronotype (M = 14.73, SD = 4.35) and higher depressive symptom scores that were half a standard deviation higher compared to community norms (M = 55.80, SD = 10.01). Multiple linear regression controlling for age, sex, and TST showed that greater eveningness preferences predicted higher symptoms of depression, p<0.01, explaining 2.76% additional variance in depression scores above that of the covariates. Overall, sleep clinic outpatients had an intermediate chronotype and above average depressive symptoms. The findings are consistent with existing literature in other populations indicating that eveningness may be a risk factor for greater symptoms of depression. Future studies need to explore whether interventions to alter chronotype may benefit symptoms of depression in individuals with sleep complaints.
- 1 March 2023
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 41 (01/02) , 045-058
Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive, metabolic, and psychological sequelae that affects 8 to 13% of reproductive-aged women and 3 to 11% of adolescent girls. Sleep is often compromised in women with PCOS due to increased rates of sleep problems, with the most established problem being obstructive sleep apnea (OSA). OSA is highly prevalent in reproductive-aged adult women with PCOS, but not so in adolescence. The international evidence-based PCOS guideline to improve health outcomes in women with PCOS indicated routine screening to identify and alleviate symptoms of OSA. The guidelines, however, did not weigh other multidimensional constructs of sleep health such as sleep disturbances (e.g., sleep quality and quantity), beyond OSA. This is perhaps due to the lack of research and existing mixed findings in the area of PCOS and sleep health. This narrative review summarizes the current knowledge about OSA and expands further to include the limited knowledge about other sleep problems in PCOS among reproductive-aged women and adolescent girls. We broadly cover the prevalence, risk factors, and mechanisms of sleep problems in PCOS and their relationship with cardiometabolic and psychological health. A brief summary on treatment and intervention strategies for sleep problems in PCOS and future recommendations will be deliberated.
- 1 March 2023
- Published by Georg Thieme Verlag KG in Seminars in Reproductive Medicine
- Vol. 41 (01/02) , 045-058
Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
Polycystic ovary syndrome (PCOS) is a common hormonal condition with reproductive, metabolic, and psychological sequelae that affects 8 to 13% of reproductive-aged women and 3 to 11% of adolescent girls. Sleep is often compromised in women with PCOS due to increased rates of sleep problems, with the most established problem being obstructive sleep apnea (OSA). OSA is highly prevalent in reproductive-aged adult women with PCOS, but not so in adolescence. The international evidence-based PCOS guideline to improve health outcomes in women with PCOS indicated routine screening to identify and alleviate symptoms of OSA. The guidelines, however, did not weigh other multidimensional constructs of sleep health such as sleep disturbances (e.g., sleep quality and quantity), beyond OSA. This is perhaps due to the lack of research and existing mixed findings in the area of PCOS and sleep health. This narrative review summarizes the current knowledge about OSA and expands further to include the limited knowledge about other sleep problems in PCOS among reproductive-aged women and adolescent girls. We broadly cover the prevalence, risk factors, and mechanisms of sleep problems in PCOS and their relationship with cardiometabolic and psychological health. A brief summary on treatment and intervention strategies for sleep problems in PCOS and future recommendations will be deliberated.
- 6 September 2022
- Published by Wiley in Respirology
- Vol. 27 (10) , 812-814
Sleep medicine is more than just obstructive sleep apnoea
- 6 September 2022
- Published by Wiley in Respirology
- Vol. 27 (10) , 812-814
Sleep medicine is more than just obstructive sleep apnoea